Cano Health, Inc.
Cano Health, Inc. Fundamental Analysis
Cano Health, Inc. (CANO-WT) shows weak financial fundamentals with a PE ratio of -0.03, profit margin of -15.64%, and ROE of -1.49%. The company generates $1188.0B in annual revenue with N/A year-over-year growth of N/A.
Key Strengths
Areas of Concern
The stock receives a Fundamental Health Score of -266.2/100 based on profitability, valuation, growth, and balance sheet metrics. The F grade reflects weak fundamentals and significant financial concerns.
Fundamental Health Score
We analyze CANO-WT's fundamental strength across five key dimensions:
Efficiency Score
WeakCANO-WT struggles to generate sufficient returns from assets.
Valuation Score
ExcellentCANO-WT trades at attractive valuation levels.
Growth Score
WeakCANO-WT faces weak or negative growth trends.
Financial Health Score
ModerateCANO-WT shows balanced financial health with some risks.
Profitability Score
WeakCANO-WT struggles to sustain strong margins.
Key Financial Metrics
Is CANO-WT Expensive or Cheap?
P/E Ratio
CANO-WT trades at -0.03 times earnings. This suggests potential undervaluation.
PEG Ratio
When adjusting for growth, CANO-WT's PEG of -0.00 indicates potential undervaluation.
Price to Book
The market values Cano Health, Inc. at 0.04 times its book value. This may indicate undervaluation.
EV/EBITDA
Enterprise value stands at 5.87 times EBITDA. This is generally considered low.
How Well Does CANO-WT Make Money?
Net Profit Margin
For every $100 in sales, Cano Health, Inc. keeps $-15.64 as profit after all expenses.
Operating Margin
Core operations generate -3.27 in profit for every $100 in revenue, before interest and taxes.
ROE
Management delivers $-1.49 in profit for every $100 of shareholder equity.
ROA
Cano Health, Inc. generates $-22.21 in profit for every $100 in assets, demonstrating efficient asset deployment.
Following the Money - Real Cash Generation
Operating Cash Flow
Cano Health, Inc. generates limited operating cash flow of $-63.47B, signaling weaker underlying cash strength.
Free Cash Flow
Cano Health, Inc. generates weak or negative free cash flow of $-84.95B, restricting financial flexibility.
FCF Per Share
Each share generates $-40.05 in free cash annually.
FCF Yield
CANO-WT converts -15.75% of its market value into free cash.
Financial Ratios Analysis
Valuation Ratios
P/E Ratio
Price to earnings ratio
-0.03
vs 25 benchmark
PEG Ratio
Price/earnings to growth ratio
-0.00
vs 25 benchmark
P/B Ratio
Price to book value ratio
0.04
vs 25 benchmark
P/S Ratio
Price to sales ratio
0.005
vs 25 benchmark
Financial Health
Debt/Equity
Total debt to shareholders' equity
4.70
vs 25 benchmark
Current Ratio
Current assets to current liabilities
1.63
vs 25 benchmark
Efficiency Ratios
ROE
Return on equity percentage
-1.49
vs 25 benchmark
ROA
Return on assets percentage
-0.22
vs 25 benchmark
ROCE
Return on capital employed
-0.05
vs 25 benchmark
How CANO-WT Stacks Against Its Sector Peers
| Metric | CANO-WT Value | Sector Average | Performance |
|---|---|---|---|
| P/E Ratio | -0.03 | 28.96 | Better (Cheaper) |
| ROE | -149.33% | 716.00% | Weak |
| Net Margin | -15.64% | -46137.00% (disorted) | Weak |
| Debt/Equity | 4.70 | 0.35 | Weak (High Leverage) |
| Current Ratio | 1.63 | 4.52 | Neutral |
| ROA | -22.21% | -17407.00% (disorted) | Weak |
CANO-WT outperforms its industry in 1 out of 6 key metrics, but lagging in ROE.
Historical Growth Performance
5-Year Growth Trajectory
This section reviews Cano Health, Inc.'s 5-year compound annual growth rate (CAGR) and compares its performance against the typical investment style of its industry.
Revenue CAGR
N/A
Industry Style: Defensive, Growth, Innovation
EPS CAGR
N/A
Industry Style: Defensive, Growth, Innovation
FCF CAGR
N/A
Industry Style: Defensive, Growth, Innovation